abstract |
The present invention concerns analogues of hydroxychloroquine, having an activity greater than hydroxychloroquine but without retinal toxicity, of formula (I), the pharmaceutically acceptable salts, solvates or hydrates of same, the method for preparing same and the use thereof in the treatment of lupus erythematosus. |